{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:41:54Z","timestamp":1791582114570,"version":"4.3.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100004324","name":"Astellas Pharma Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12955-017-0819-1","type":"journal-article","created":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T11:08:00Z","timestamp":1515064080000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Development and content validation of a patient-reported endometriosis pain daily diary"],"prefix":"10.1186","volume":"16","author":[{"given":"Floortje E.","family":"van Nooten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Cline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste A.","family":"Elash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Paty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Reaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,4]]},"reference":[{"key":"819_CR1","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1093\/humrep\/dei135","volume":"20","author":"S Kennedy","year":"2005","unstructured":"Kennedy S, Bergqvist A, Chapron C, D\u2019Hooghe T, Dunselman G, Greb R, et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 2005;20:2698\u2013704.","journal-title":"Hum Reprod"},{"key":"819_CR2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10815-010-9436-1","volume":"27","author":"C Bulletti","year":"2010","unstructured":"Bulletti C, Coccia ME, Battistoni S, Borini A. Endometriosis and infertility. J Assist Reprod Genet. 2010;27:441\u20137.","journal-title":"J Assist Reprod Genet"},{"key":"819_CR3","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/humrep\/det284","volume":"28","author":"AA De Graaff","year":"2013","unstructured":"De Graaff AA, D'Hooghe TM, Dunselman GA, Dirksen CD, Hummelshoj L, Consortium WE, et al. The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey. Hum Reprod. 2013;28:2677\u201385.","journal-title":"Hum Reprod"},{"key":"819_CR4","doi-asserted-by":"crossref","unstructured":"Nnoaham KE, Hummelshoj L, Webster P, d'Hooghe T, de Cicco NF, de Cicco NC, et al. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril. 2011;96:366\u201373. e8","DOI":"10.1016\/j.fertnstert.2011.05.090"},{"key":"819_CR5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0002-9378(81)90478-6","volume":"139","author":"KO Biberoglu","year":"1981","unstructured":"Biberoglu KO, Behrman SJ. Dosage aspects of danazol therapy in endometriosis: short-term and long-term effectiveness. Am J Obstet Gynecol. 1981;139:645\u201354.","journal-title":"Am J Obstet Gynecol"},{"key":"819_CR6","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1177\/1933719114549848","volume":"21","author":"B Carr","year":"2014","unstructured":"Carr B, Dmowski WP, O'Brien C, Jiang P, Burke J, Jimenez R, et al. Elagolix, an oral GnRH antagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: effects on bone mineral density. Reprod Sci. 2014;21:1341\u201351.","journal-title":"Reprod Sci"},{"key":"819_CR7","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jval.2011.06.013","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 2--assessing respondent understanding. Value Health. 2011;14:978\u201388.","journal-title":"Value Health"},{"key":"819_CR8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jval.2015.08.006","volume":"18","author":"MK Walton","year":"2015","unstructured":"Walton MK, Powers JH 3rd, Hobart J, Patrick D, Marquis P, Vamvakas S, et al. Clinical outcome assessments: conceptual foundation-report of the ISPOR clinical outcomes assessment - emerging good practices for outcomes research task force. Value Health. 2015;18:741\u201352.","journal-title":"Value Health"},{"key":"819_CR9","unstructured":"US Dept of Health and Human Services. FDA guidance for industry - patient-reported outcome measures: use in medical product development to support labeling claims. 2009. https:\/\/www.fda.gov\/downloads\/Drugs\/%E2%80%A6\/Guidances\/UCM193282.pdf . Accessed Oct 2016."},{"key":"819_CR10","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1023\/B:QURE.0000021316.79349.af","volume":"13","author":"G Jones","year":"2004","unstructured":"Jones G, Jenkinson C, Kennedy S. Evaluating the responsiveness of the endometriosis health profile questionnaire: the EHP-30. Qual Life Res. 2004;13:705\u201313.","journal-title":"Qual Life Res"},{"key":"819_CR11","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1023\/B:QURE.0000021321.48041.0e","volume":"13","author":"G Jones","year":"2004","unstructured":"Jones G, Jenkinson C, Kennedy S. Development of the short form endometriosis health profile questionnaire: the EHP-5. Qual Life Res. 2004;13:695\u2013704.","journal-title":"Qual Life Res"},{"key":"819_CR12","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1093\/humrep\/del231","volume":"21","author":"G Jones","year":"2006","unstructured":"Jones G, Jenkinson C, Taylor N, Mills A, Kennedy S. Measuring quality of life in women with endometriosis: tests of data quality, score reliability, response rate and scaling assumptions of the endometriosis health profile questionnaire. Hum Reprod. 2006;21:2686\u201393.","journal-title":"Hum Reprod"},{"key":"819_CR13","first-page":"258","volume":"98","author":"G Jones","year":"2001","unstructured":"Jones G, Kennedy S, Barnard A, Wong J, Jenkinson C. Development of an endometriosis quality-of-life instrument: the endometriosis health Profile-30. Obstet Gynecol. 2001;98:258\u201364.","journal-title":"Obstet Gynecol"},{"key":"819_CR14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1477-7525-8-64","volume":"8","author":"LS Deal","year":"2010","unstructured":"Deal LS, DiBenedetti DB, Williams VS, Fehnel SE. The development and validation of the daily electronic endometriosis pain and bleeding diary. Health Qual Life Outcomes. 2010;8:64.","journal-title":"Health Qual Life Outcomes"},{"key":"819_CR15","unstructured":"Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products, 2005.\u00a0 http:\/\/www.ispor.org\/workpaper\/emea-hrql-guidance.pdf .\u00a0Accessed Oct 2016."},{"key":"819_CR16","first-page":"73","volume-title":"Cognitive aspects of survey methodology: building a bridge between disciplines","author":"R Tourangeau","year":"1984","unstructured":"Tourangeau R. Cognitive science and survey methods. In: Jabine T, Straf M, Tanur J, Tourangeau R, editors. Cognitive aspects of survey methodology: building a bridge between disciplines. Washington, D.C.: National Academy Press; 1984. p. 73\u2013100."},{"key":"819_CR17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1524-4733.2005.04054.x","volume":"8","author":"D Wild","year":"2005","unstructured":"Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health. 2005;8:94\u2013104.","journal-title":"Value Health"},{"key":"819_CR18","volume-title":"User's manual for ATLAS.Ti 5.0","author":"T Muhr","year":"2004","unstructured":"Muhr T. User's manual for ATLAS.Ti 5.0. Berlin: ATLASti Scientific Software Development GmbH; 2004."}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-017-0819-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T20:28:03Z","timestamp":1589833683000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-017-0819-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,4]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["819"],"URL":"https:\/\/doi.org\/10.1186\/s12955-017-0819-1","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,4]]},"article-number":"3"}}